RESEARCH
EPIDIOLEX® (cannabidiol)
To learn more, including important safety information and access to the full prescribing information, visit EPIDIOLEX.com if you are a patient or caregiver and EPIDIOLEXhcp.com if you are a healthcare professional.
EPIDIOLEX® (cannabidiol) is the first prescription formulation of highly purified, plant-derived cannabidiol (CBD).
As an FDA-approved therapy, EPIDIOLEX® (cannabidiol) has undergone rigorous clinical testing and a regulated manufacturing process, leading to accurate labeling and consistent dosing.
Medical Information
If you are a healthcare professional interested in additional scientific and clinical information on Greenwich Biosciences products, EPIDIOLEX, and cannabinoids, or would like to submit a medical request form, visit Medical Information.
EPIDIOLEX Clinical Trials
For the most up-to-date list of publicly and privately supported clinical studies of human participants treated with EPIDIOLEX, visit ClinicalTrials.gov.
Pipeline
Review our product candidates, including compounds in phase 1, 2, and 3 trials for glioblastoma, schizophrenia, autism spectrum disorders, and epilepsy.